Results
1 -
6 of
6Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report, Journal of Medical Case Reports Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea, Cancer Chemotherapy and Pharmacology Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract, Current Treatment Options in Oncology Telotristat Ethyl: First Global Approval, Drugs Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea, Drugs Telotristat for CSD treatment: "minimal" budget impact, PharmacoEconomics & Outcomes News